- Home
- RCUS vs AIV Comparison
RCUS vs AIV Comparison
Compare RCUS & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- AIV
- Stock Information
- Founded
- RCUS 2015
- AIV 1975
- Country
- RCUS United States
- AIV United States
- Employees
- RCUS N/A
- AIV N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- AIV Real Estate Investment Trusts
- Sector
- RCUS Health Care
- AIV Real Estate
- Exchange
- RCUS Nasdaq
- AIV Nasdaq
- Market Cap
- RCUS 1.4B
- AIV 1.2B
- IPO Year
- RCUS 2018
- AIV 1994
- Fundamental
- Price
- RCUS $15.70
- AIV $8.79
- Analyst Decision
- RCUS Strong Buy
- AIV
- Analyst Count
- RCUS 10
- AIV 0
- Target Price
- RCUS $35.88
- AIV N/A
- AVG Volume (30 Days)
- RCUS 611.6K
- AIV 877.1K
- Earning Date
- RCUS 11-05-2024
- AIV 11-04-2024
- Dividend Yield
- RCUS N/A
- AIV N/A
- EPS Growth
- RCUS N/A
- AIV N/A
- EPS
- RCUS N/A
- AIV N/A
- Revenue
- RCUS $247,000,000.00
- AIV $199,278,000.00
- Revenue This Year
- RCUS $132.82
- AIV N/A
- Revenue Next Year
- RCUS N/A
- AIV $7.04
- P/E Ratio
- RCUS N/A
- AIV N/A
- Revenue Growth
- RCUS 104.13
- AIV 10.79
- 52 Week Low
- RCUS $12.95
- AIV $5.63
- 52 Week High
- RCUS $21.79
- AIV $9.49
- Technical
- Relative Strength Index (RSI)
- RCUS 44.40
- AIV 45.85
- Support Level
- RCUS $15.96
- AIV $8.79
- Resistance Level
- RCUS $17.67
- AIV $9.16
- Average True Range (ATR)
- RCUS 0.90
- AIV 0.20
- MACD
- RCUS -0.20
- AIV -0.02
- Stochastic Oscillator
- RCUS 3.79
- AIV 19.54
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. The company generates majority of revenue from operating segment.